[ad_1]
The study involved nearly 400 healthy people who showed an immune response to the weakened virus.
The scientific journal The Lancet published this July 6, a survey of an international team of scientists, led by virologist Dan Barouch of Harvard Medical School, who claims to be close to obtaining a medical report. an effective vaccine against AIDS.
The study tests were conducted on 393 healthy adults in East and Southern Africa, Thailand and the United States. Part of the volunteers received the experimental vaccine with four injections given within 48 weeks, while others received a placebo.
The vaccine is composed of several types of HIV viruses handled to be most effective. Harmless to the subjects of the experiment. The authors of the research aimed to elicit an immune response in people who received the vaccine and, according to the study, they were successful.
In addition, experiments confirmed that the vaccine is safe, since only five 393 volunteers reported side effects after receiving injections: back or abdominal pain, diarrhea, and vertigo.
It should be mentioned that the same vaccine has already been tested by scientists in 72 macaques, two-thirds of whom did not become ill after the researchers tried to inoculate the virus. The next step in the investigation will be to test the new vaccine in 2,600 women in southern Africa.
The French scientist Jean-Daniel Lelievre of the Vaccine Research Institute told AFP that it was a phenomenal breakthrough, but for the moment, it's not no question of a definitive vaccine. "At best," studies could result in a vaccine that can be administered in "almost 10 years."
[ad_2]
Source link
